EMT is characterized by the loss of epithelial markers, such as E‐cadherin, followed by upregulation of mesenchymal markers, such as N‐cadherin; resulting in promotion of cell migration and invasion of cancer cells as the initial step of metastasis.37 The gene discussed is CDH2; the disease is cancer.